Company: SCYX
Filing Date: 2025-03-12
Form Type: 10-K
Source: 0000950170-25-038044
Chunk: 219

Company: SCYNEXIS INC
Filing Date: 2025-03-12
Form: 10-K
Item: Item 8
Chunk 219
---
    $
    (376,535
    )
     
    $
    55,077

The accompanying notes are an integral part of the financial statements.

61

SCYNEXIS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

    Years Ended December 31,

    2024

    2023

    Cash flows from operating activities:

    Net (loss) income
     
    $
    (21,288
    )
     
    $
    67,041

    Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:

    Depreciation and amortization

    —

    580

    Stock-based compensation expense

    3,346

    2,624

    Accretion of investment discount

    (1,340
    )

    (1,340
    )

    Amortization of debt issuance costs and discount

    1,726

    2,994

    Change in fair value of warrant liabilities

    (13,812
    )

    3,166

    Change in fair value of derivative liability

    (196
    )

    154

    Noncash operating lease expense for right-of-use asset

    272

    230

    Inventory impairment expense

    —

    14,577

    Write off of deferred asset for commitment fees

    —

    514

    Prepayment fee for loan payable payment

    —

    263

    Changes in operating assets and liabilities:

    Prepaid expenses, other assets, deferred costs, and other

    3,388

    (2,971
    )

    License agreement contract asset

    9,854

    (19,363
    )

    License agreement receivable

    1,710

    (2,463
    )

    Accounts receivable

    —

    2,101

    Inventory

    —

    (8,849
    )

    Accounts payable

    (2,650
    )

    1,172

    Accrued expenses

    (3,701
    )

    1,866

    Deferred revenue

    (979
    )

    3,916

    Other liabilities and other

    (339
    )

    (6,053
    )

    Net cash (used in) provided by operating activities

    (24,009
    )